IL105223A0 - Cyclohexane-ylidenes and pharmaceutical compositions containing them - Google Patents
Cyclohexane-ylidenes and pharmaceutical compositions containing themInfo
- Publication number
- IL105223A0 IL105223A0 IL10522393A IL10522393A IL105223A0 IL 105223 A0 IL105223 A0 IL 105223A0 IL 10522393 A IL10522393 A IL 10522393A IL 10522393 A IL10522393 A IL 10522393A IL 105223 A0 IL105223 A0 IL 105223A0
- Authority
- IL
- Israel
- Prior art keywords
- ylidenes
- cyclohexane
- pharmaceutical compositions
- compositions containing
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C255/46—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of non-condensed rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D303/46—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by amide or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86211292A | 1992-04-02 | 1992-04-02 | |
US96876092A | 1992-10-30 | 1992-10-30 | |
PCT/US1993/001988 WO1993019747A1 (en) | 1992-04-02 | 1993-03-05 | Compounds useful for treating allergic and inflammatory diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
IL105223A0 true IL105223A0 (en) | 1994-08-26 |
Family
ID=27127669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10522393A IL105223A0 (en) | 1992-04-02 | 1993-03-30 | Cyclohexane-ylidenes and pharmaceutical compositions containing them |
Country Status (10)
Country | Link |
---|---|
US (1) | US5602173A (xx) |
EP (1) | EP0634930A4 (xx) |
JP (1) | JP3195352B2 (xx) |
CN (1) | CN1094711A (xx) |
AU (1) | AU3738293A (xx) |
IL (1) | IL105223A0 (xx) |
MA (1) | MA22923A1 (xx) |
MX (1) | MX9301903A (xx) |
SI (1) | SI9300170A (xx) |
WO (1) | WO1993019747A1 (xx) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69332987T2 (de) * | 1992-04-02 | 2004-05-19 | Smithkline Beecham Corp. | Verbindungen verwendbar für die Behandlung von Allergien und Entzündungskrankheiten |
GB9312853D0 (en) | 1993-06-22 | 1993-08-04 | Euro Celtique Sa | Chemical compounds |
US5646156A (en) * | 1994-04-25 | 1997-07-08 | Merck & Co., Inc. | Inhibition of eosinophil activation through A3 adenosine receptor antagonism |
US5591776A (en) | 1994-06-24 | 1997-01-07 | Euro-Celtique, S.A. | Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV |
US5922751A (en) | 1994-06-24 | 1999-07-13 | Euro-Celtique, S.A. | Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same |
US5578576A (en) * | 1994-09-02 | 1996-11-26 | Dalhousie University | Method and composition for treating intestinal wounds or ulcers |
DE69531506T2 (de) * | 1994-12-13 | 2004-06-24 | Euroceltique S.A. | Arylthioxanthine |
WO1996020160A1 (en) * | 1994-12-23 | 1996-07-04 | Smithkline Beecham Corporation | 1,3,3-(trisubstituted)cyclohexane dimers and related compounds |
JPH10511659A (ja) * | 1994-12-23 | 1998-11-10 | スミスクライン・ビーチャム・コーポレイション | 1,4,4−(三置換)シクロヘキサン単量体および関連する化合物 |
JPH10511662A (ja) * | 1994-12-23 | 1998-11-10 | スミスクライン・ビーチャム・コーポレイション | 1,4,4−(三置換)シクロヘキサン二量体および関連化合物 |
US5902824A (en) * | 1995-05-18 | 1999-05-11 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Phenyldihydrobenzofuranes |
DE59610031D1 (de) * | 1995-05-18 | 2003-02-06 | Altana Pharma Ag | Cyclohexyldihydrobenzofurane |
US6268373B1 (en) | 1995-06-07 | 2001-07-31 | Euro-Celtique S.A. | Trisubstituted thioxanthines |
US6166041A (en) | 1995-10-11 | 2000-12-26 | Euro-Celtique, S.A. | 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma |
US5891883A (en) * | 1995-12-21 | 1999-04-06 | Smithkline Beecham Corporation | 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds |
US6075016A (en) | 1996-04-10 | 2000-06-13 | Euro-Celtique S.A. | 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity |
US5744473A (en) * | 1996-09-16 | 1998-04-28 | Euro-Celtique, S.A. | PDE IV inhibitors: "bis-compounds" |
EP1524268B1 (en) * | 1997-02-12 | 2007-01-17 | Smithkline Beecham Corporation | Compounds and method for preparing sustituted 4-phenyl-4-cyanocyclohexanoic acids |
DK1295869T3 (da) * | 1997-02-12 | 2005-11-21 | Smithkline Beecham Corp | Forbindelser og fremgangsmåde til fremstilling af substituerede 4-phenyl-4-cyanocyclohexansyrer |
AR012550A1 (es) * | 1997-02-12 | 2000-11-08 | Smithkline Beecham Corp | Metodo para preparar acidos 4-fenil-4-ciano-ciclohexanoicos sustituidos y compuestos intermediarios |
UY26268A1 (es) * | 1999-08-06 | 2001-01-31 | Smithkline Beecham Corp | Procedimiento para preparar acidos a traves de alfa-cloroep xi- esteres ley 17164 art 127 |
US20040220424A1 (en) * | 1999-08-06 | 2004-11-04 | Smithkline Beecham Corporation | Process for preparing acids via alpha-chloroepoxy esters |
EP2193808A1 (en) | 1999-08-21 | 2010-06-09 | Nycomed GmbH | Synergistic combination |
WO2001068600A2 (en) * | 2000-03-16 | 2001-09-20 | Inflazyme Pharmaceuticals Limited | Benzylated pde4 inhibitors |
US7109342B2 (en) * | 2000-08-11 | 2006-09-19 | Ono Pharmaceutical Co., Ltd. | Piperidine derivatives and agent comprising the derivative as active ingredient |
US7425567B2 (en) * | 2002-02-08 | 2008-09-16 | Ono Pharmaceutical Co., Ltd. | Piperidine derivative compounds and drugs containing the compounds as the active ingredient |
TW200302724A (en) * | 2002-02-08 | 2003-08-16 | Ono Pharmaceutical Co | Piperiding derivative compound and pharmaceuticals containing same as active ingredient |
AU2003253130A1 (en) * | 2002-08-19 | 2004-03-03 | Glenmark Pharmaceuticals Limited | Condensed heterocyclic compounds as pde-iv inhibitors for the treatment of inflammatory and allergic disorders |
DE60317918T2 (de) | 2002-10-23 | 2009-01-29 | Glenmark Pharmaceuticals Ltd. | Tricyclische verbindungen zur behandlung von entzündlichen und allergischen erkrankungen verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
EA200501548A1 (ru) | 2003-04-01 | 2006-02-24 | Апплайд Резеч Системз Арс Холдинг Н.В. | Ингибиторы фосфодиэстераз при бесплодии |
BRPI0409747A (pt) | 2003-04-11 | 2006-05-09 | Glenmark Pharmaceuticals Sa | novos compostos heterocìclicos úteis para tratamento de distúrbios inflamatórios e alérgicos, processo para sua preparação e composições farmacêuticas contendo estes |
US20050026883A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
US20090274676A1 (en) * | 2003-07-31 | 2009-11-05 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
US20050085430A1 (en) * | 2003-07-31 | 2005-04-21 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
MX2007004400A (es) | 2004-10-13 | 2007-06-19 | Glenmark Pharmaceuticals Sa | Procedimiento para la preparacion de n-(3,5-dicloropirid-a-il)-4- ifluorometoxi-8-metanosulfonamido-dibenzo [b,d] difuran-1-carboxamida. |
DK1831227T3 (da) | 2004-12-17 | 2013-08-19 | Glenmark Pharmaceuticals Sa | Hidtil ukendte, heterocykliske forbindelser, der er anvendelige til behandling af inflammatoriske og allergiske forstyrrelser |
WO2006064355A2 (en) | 2004-12-17 | 2006-06-22 | Glenmark Pharmaceuticals S.A. | Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
EA020466B1 (ru) | 2007-06-04 | 2014-11-28 | Синерджи Фармасьютикалз Инк. | Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний |
CA2726917C (en) | 2008-06-04 | 2018-06-26 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
CA2730603C (en) | 2008-07-16 | 2019-09-24 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
WO2012118972A2 (en) | 2011-03-01 | 2012-09-07 | Synegy Pharmaceuticals Inc. | Process of preparing guanylate cyclase c agonists |
WO2014131024A2 (en) | 2013-02-25 | 2014-08-28 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
CN113388007A (zh) | 2013-06-05 | 2021-09-14 | 博士医疗爱尔兰有限公司 | 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法 |
MX2016001714A (es) | 2013-08-09 | 2016-10-03 | Ardelyx Inc | Compuestos y metodos para inhibir el transporte de fosfato. |
US20200368223A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Methods for inhibiting phosphate transport |
-
1993
- 1993-03-05 JP JP51744493A patent/JP3195352B2/ja not_active Expired - Fee Related
- 1993-03-05 MX MX9301903A patent/MX9301903A/es unknown
- 1993-03-05 EP EP93906296A patent/EP0634930A4/en not_active Withdrawn
- 1993-03-05 AU AU37382/93A patent/AU3738293A/en not_active Abandoned
- 1993-03-05 WO PCT/US1993/001988 patent/WO1993019747A1/en not_active Application Discontinuation
- 1993-03-05 US US08/313,096 patent/US5602173A/en not_active Expired - Lifetime
- 1993-03-30 IL IL10522393A patent/IL105223A0/xx unknown
- 1993-04-01 MA MA23149A patent/MA22923A1/fr unknown
- 1993-04-02 CN CN93105721A patent/CN1094711A/zh active Pending
- 1993-04-02 SI SI9300170A patent/SI9300170A/sl unknown
Also Published As
Publication number | Publication date |
---|---|
US5602173A (en) | 1997-02-11 |
JPH07508261A (ja) | 1995-09-14 |
SI9300170A (sl) | 1993-12-31 |
MA22923A1 (fr) | 1994-04-01 |
WO1993019747A1 (en) | 1993-10-14 |
EP0634930A1 (en) | 1995-01-25 |
AU3738293A (en) | 1993-11-08 |
MX9301903A (es) | 1994-08-31 |
CN1094711A (zh) | 1994-11-09 |
JP3195352B2 (ja) | 2001-08-06 |
EP0634930A4 (en) | 1995-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL105218A0 (en) | Hexanones and pharmaceutical compositions containing them | |
IL105223A0 (en) | Cyclohexane-ylidenes and pharmaceutical compositions containing them | |
IL105220A0 (en) | Cyclohexanylidene compounds and pharmaceutical compositions containing them | |
IL111221A0 (en) | N-alkyl-n- arylpyrimidinamine derivatives and pharmaceutical compositions containing them | |
IL106431A0 (en) | Aminediol derivatives and pharmaceutical compositions containing the same | |
IL114622A0 (en) | Heteroaryl-oxazolidinones and pharmaceutical compositions containing them | |
IL105221A0 (en) | Cyclohexane derivatives and pharmaceutical compositions containing them | |
IL95351A0 (en) | 17beta-acyl-4-aza-5alpha-androst-1-en-3-ones and pharmaceutical compositions containing them | |
IL106553A0 (en) | Substituted imidazoles and pharmaceutical compositions containing them | |
GB9319500D0 (en) | Pharmaceutical composition | |
IL106098A0 (en) | Heteroarylnaphthalenes and pharmaceutical compositions containing them | |
IL97122A0 (en) | Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them | |
AU5100393A (en) | Diindolo compounds and pharmaceutical compositions containing them | |
IL108073A0 (en) | Substituted 6-azaandrostenones their preparation and pharmaceutical compositions containing them | |
HU9303304D0 (en) | Thienyl-pyrrolidinyl-carbapenem-derivatives providing antibiotic effect and pharmaceutical compositions containing it | |
GB2272375B (en) | Pharmaceutical composition | |
EP0587047A3 (en) | Gestagenes containing pharmaceutical composition | |
IL105551A0 (en) | Quinazolines and pharmaceutical compositions containing them | |
IL107611A0 (en) | Steroid compounds and pharmaceutical compositions containing them | |
IL104944A0 (en) | Anti-tumor agents and pharmaceutical compositions containing the same | |
GB9221707D0 (en) | Pharmaceutical composition | |
IL106214A0 (en) | Thf-ypsilon2 analogs and pharmaceutical compositions comprising them | |
IL106352A0 (en) | Pyridoindolo-benzodiazepines and pharmaceutical compositions containing them | |
IL106080A0 (en) | Pharmaceutical compositions containing amidines and novel amidines | |
IL103132A0 (en) | Digitalis-like compounds and pharmaceutical compositions containing them |